bioAffinity Technologies partners with Pictor to develop asthma, COPD diagnostics - BIAF News | RalliesbioAffinity Technologies partners with Pictor to develop asthma, COPD diagnostics
B
BIAF• Partnership to develop asthma and COPD diagnostics
- bioAffinity Technologies partnered with Pictor to develop and commercialize next-generation diagnostic tests for asthma and COPD.
- The collaboration combines bioAffinity’s sputum-based flow cytometry with Pictor’s targeted proteomics to profile immune cells and cytokines.
- The program targets a high-throughput lab test to guide precision treatment decisions, including use of FDA-approved biologics.
- Initial launches are expected as CLIA laboratory developed tests; bioAffinity will own test-related IP, while Pictor will retain platform IP.
•
